DOCSLIB.ORG

Septic Shock V9.0 Patient Flow Map

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Septic Shock V9.0 Patient Flow Map Septic Shock v9.0 Patient Flow Map Approval & Citation Summary of Version Changes Explanation of Evidence Ratings Patient presents to the ED with fever and/or concern for infection and ED sepsis score ≥ 6 ! BPA fires Use the ED Suspected Septic Shock RN and Well-appearing patients should be placed pathway for all ill on the appropriate ED CSW pathway for Provider appearing patients their underlying condition (e.g. ED No including HemOnc/BMT, Huddle: HemOnc BMT Suspected Infection, ED Central Line Infection Is the patient ill Suspected Central Line Infection, ED and Neonates appearing? Neonatal Fever) Yes ED Septic Shock Pathway • Use ED Suspected Septic Shock Plan • Antibiotics and blood cultures for specific populations included Inpatient Admit Criteria Does NOT meet Inpatient Admit Minute criteria • Resolution of hypotension and no • Admit to ICU ongoing signs of sepsis after ≤ 40 ml / 60 Huddle: YES NO • Follow ICU Septic Shock Pathway kg NS bolus Does patient meet • Use PICU/CICU Septic Shock Admit • First dose antibiotics administered Inpatient admit Plan • RISK to follow criteria? • Antibiotics, blood cultures for specific populations included in sub plans Previously healthy > 30 days RISK RN to follow all • Admit to General Medicine patients admitted with • Follow Admit from ED Septic Shock concern for sepsis Pathway • Use Inpatient Septic Shock Plan ! Concern for evolving sepsis Previously healthy < 30 days Any • Admit to General Medicine admitted • Call RRT or Code Blue • Follow Neonatal Fever Pathway patient with • Follow Inpatient New Septic Shock • Use Inpatient Fever Neonatal 0-30 concern for new Pathway days Plan or evolving septic • Use Inpatient New Septic Shock Plan shock HemOnc/ BMT Suspected Infection • Admit to Cancer Care Unit Signs & Symptoms of • Follow Hemonc/BMT Suspected Sepsis Infection Pathway th • Use Hemonc Suspected Infection • Hypotension(MAP ≤ 5 Admit Plan percentile for age) • Tachycardia Central Line Infection • Poor perfusion • Admit to General Medicine/GI • Reduced urine output Transplant • Tachypnea/ new oxygen • Follow Central Line Infection Pathway requirement • Use Admit orders + Central Line • Mental status changes Infection Plan For questions concerning this pathway, Last Updated: May 2021 contact [email protected] Next Expected Revision: December 2021 © 2021 Seattle Children’s Hospital, all rights reserved, Medical Disclaimer Septic Shock v9.0 Suspected Septic Shock (ED) PHASE I Approval & Citation Explanation of Evidence Ratings Inclusion Criteria Summary of Version Changes • Any patient with clinical concern Signs & Symptoms of for sepsis/septic shock OR Sepsis Urgent Care Transfer ED Sepsis Score of 6 or greater • Hypotension(MAP ≤ 5th Recommendations AND ED attending/fellow percentile for age) • Concern for septic shock assessment with concern for • Tachycardia • Initiate ALS transfer sepsis/septic shock • Poor perfusion • Provider to Provider handoff • Reduced urine output • Continue pathway while Exclusion Criteria • Tachypnea/ new oxygen waiting for transfer • None requirement • Mental status changes SHOCK TIME GOALS Activate Septic Shock Pathway ! • Assess airway, breathing, circulation Activate Time Zero = • Provide supplemental oxygen ED Sepsis ED Septic • Reassess vital signs every 5 minutes Internal Shock Pathway • Order appropriate antibiotics Response Activation Access/Labs Initial Fluid Resuscitation • EPOC: VBG, lactate, iCa • Place 2 large bore PIVs • POCT glucose • Administer 1st bolus of 20mL/kg normal if no central line • Electrolytes, Magnesium, saline rapidly over 20 minutes OR Phosphorus 15MIN LESS 15 • BUN, Creatinine ! • Consider PIV in patients Correct • Consider 5-10mL/kg boluses if • Blood cultures with central line glucose concern for fluid intolerance • CBC + diff ! and calcium (cardiac/renal dysfunction) • If 2 unsuccessful IV • CRP attempts; consider IO • Consider ABO/RhD and • Give stress dose steroids if known antibody adrenal insufficiency Administer Antimicrobials Ongoing Resuscitation • Previously healthy patients: ceftriaxone (+vancomycin if history • Administer 2nd and 3rd bolus * of 20mL/kg of/concern for MRSA) normal saline rapidly over 20 minutes • Appropriate antibiotics for specific populations: 30MIN OR LESS until perfusion improves or • HemOnc//BMT Suspected Infection (HOBSI) ! unless rales or hepatomegaly develop • Central Line Infection Notify • Order vasoactive/inotropic drips • Neonatal Fever (0-30 days) ICU • Consider blood products as indicated • Consider history of resistant organisms Consider ICU bed request * BMT patients: consider vasoactive / Initiate vasoactive/inotropic drips inotropic drips after 2nd NS bolus for Fluid Refractory Shock • Epinephrine for cold shock Bedside Huddle Respiratory Support (ED, ICU, +/- • Norepinephrine for warm shock • Consider ET intubation for ongoing 60MIN Hospitalist) •• TitrateTitrate drips drips toto resuscitationresuscitation goalsgoals respiratory distress or altered mental •• ConsiderConsider broadening broadening antibioticantibiotic status coveragecoverage asas indicated indicated ICU Transfer Criteria • Recurrent hypotension despite > 40mL/kg fluid resuscitation in the last 12 hours Inpatient Admit Criteria • Fluid resuscitation includes either crystalloid or colloid • Hypotension (MAP ≤ 5th percentile for age) • Resolution of hypotension • Clinical situation not appropriate for ongoing fluid resuscitation AND no ongoing signs of • Defined as underlying cardiac disease, lung disease, existing fluid overload, sepsis after ≤ 40 ml / kg impaired renal function • First dose antibiotics • Lactate ≥ 4 or base excess < - 4 mmol administered • Sustained change in mentation or perfusion (>15 minutes) • RISK to follow • Patient requires continuous ICU monitoring or ICU level respiratory support For questions concerning this pathway, Last Updated: May 2021 contact [email protected] Next Expected Revision: December 2021 © 2021 Seattle Children’s Hospital, all rights reserved, Medical Disclaimer Septic Shock v9.0 ICU Approval & Citation Summary of Version Changes Explanation of Evidence Ratings PHASE IIA Inclusion Criteria, • Any patient admitted to the ICU with concern for septic shock Exclusion Criteria • None ICU Admission If the following have not already occurred: • IV fluid resuscitation: 40mL/kg or 2L in the first • Oxygen by face mask hour • Obtain 2 points of IV access • Order appropriate antibiotics for specific • Obtain laboratory studies per pathway populations • Assure 1st antibiotic infused within 1 hour of shock identification • Correct hypoglycemia, hypocalcemia Monitor response vital vital sign sign targets targets & clinicalclinical goals ! ! ! 2020SepsisGuidelines Fluid Intubation Respiratory choice and and Sedation Support blood Medications Infection Repeat fluid products source contol boluses Fluid Refractory Shock Consider central line, arterial line, Foley Warm Shock Cold Shock; Low BP Cold Shock; Normal BP • Titrate norepinephrine • Titrate epinephrine • Titrate epinephrine • Consider epinephrine, vasopressin • Consider norepinephrine, dobutamine • Consider milrinone, dobutamine if • PRBC if Hgb <10g/dL • PRBC if Hgb <10g/dL SCvO2 <70% or lactate elevated • Consider intubation • Consider intubation, BNP, ECHO • PRBC if Hgb <10g/dL • Consider intubation, BNP, ECHO Catecholamine Resistant Shock • Consider stress-dose hydrocortisone • Evaluate for: • Pericardial effusion Consider ECLS • Pneumothorax • Intra-abdominal hypertension • Primary cardiac dysfunction ICU to Inpatient Transfer Criteria • Weaned off of inotropic support • Not requiring ICU level of respiratory support Return to Flow • Hemodynamically stable For questions concerning this pathway, Last Updated: May 2021 contact [email protected] Next Expected Revision: December 2021 © 2021 Seattle Children’s Hospital, all rights reserved, Medical Disclaimer Septic Shock v9.0 ED Admit to Inpatient for Septic Shock Approval & Citation Summary of Version Changes Explanation of Evidence Ratings PHASE IIB ! ! Inclusion Criteria, • Any patient who is admitted Call to a service other than the code blue Call RRT for ICU on Septic Shock for imminent signs of sepsis that Pathway cardiac or require ICU presence pulmonary failure within 30 minutes Exclusion Criteria or neurologic emergency • None Signs & Symptoms of Sepsis th Patient placed on RISK dashboard • Hypotension(MAP ≤ 5 • Vital signs Q 2 hours x 8 hours percentile for age) • Tachycardia • Poor perfusion • Reduced urine output • Tachypnea/ new oxygen requirement RISK Nurse Monitoring • Mental status changes • RISK dashboard monitoring • RISK nurse Inpatient evaluation • RISK nurse determines time on dashboard • RRT activation for signs of clinical deterioration Continued Sepsis Care • Continue appropriate antibiotics for specific populations x 48 hours • Follow cultures daily, switch to narrow-spectrum antibiotics as indicated • Discontinue antibiotics after 48 hours if cultures negative and clinically improving • Advance diet as tolerated • Continue maintenance IV fluids if indicated ICU Transfer Criteria • Recurrent hypotension despite > 40mL/kg fluid resuscitation in the last 12 hours • Fluid resuscitation includes either crystalloid or colloid • Hypotension (MAP ≤ 5th percentile for age) • Clinical situation not appropriate for ongoing fluid resuscitation • Defined as underlying cardiac disease, lung disease, existing fluid overload, impaired renal function • Lactate ≥ 4 or base excess < - 4 mmol • Sustained change in
Load more

Recommended publications
  • Severe Sepsis and Septic Shock Antibiotic Guide
    Stanford Health Issue Date: 05/2017 Stanford Antimicrobial Safety and Sustainability Program Severe Sepsis and Septic Shock Antibiotic Guide Table 1: Antibiotic selection options for healthcare associated and/or immunocompromised patients • Healthcare associated: intravenous therapy, wound care, or intravenous chemotherapy within the prior 30 days, residence in a nursing home or other long-term care facility, hospitalization in an acute care hospital for two or more days within the prior 90 days, attendance at a hospital or hemodialysis clinic within the prior 30 days • Immunocompromised: Receiving chemotherapy, known systemic cancer not in remission, ANC <500, severe cell-mediated immune deficiency Table 2: Antibiotic selection options for community acquired, immunocompetent patients Table 3: Antibiotic selection options for patients with simple sepsis, community acquired, immunocompetent patients requiring hospitalization. Risk Factors for Select Organisms P. aeruginosa MRSA Invasive Candidiasis VRE (and other resistant GNR) Community acquired: • Known colonization with MDROs • Central venous catheter • Liver transplant • Prior IV antibiotics within 90 day • Recent MRSA infection • Broad-spectrum antibiotics • Known colonization • Known colonization with MDROs • Known MRSA colonization • + 1 of the following risk factors: • Prolonged broad antibacterial • Skin & Skin Structure and/or IV access site: ♦ Parenteral nutrition therapy Hospital acquired: ♦ Purulence ♦ Dialysis • Prolonged profound • Prior IV antibiotics within 90 days ♦ Abscess
    [Show full text]
  • Evaluation and Management of the Polytraumatized Patient in Various Centers
    World J. Surg. 7, 143-148, 1983 Wor Journal of Stirgery Evaluation and Management of the Polytraumatized Patient in Various Centers S. Olerud, M.D., and M. Allg6wer, M.D. The Akademiska Sjukhuset Uppsala, Sweden, and the Department of Surgery, Kantonsspital, Basel, Switzerland A questionnaire was sent to the following 6 trauma centers: Paris: Two or more peripheral, visceral, or com- University Hospital for Accident Surgery, Hannover, Fed- plex injuries with respiratory and circulatory fail- eral Republic of Germany (Prof. H. Tscherne); University ure. (This excludes patients who only have sus- of Munich, Department of Surgery, Klinikum Grossha- tained fractures.) dern, Munich, Federal Republic of Germany (Prof. G. Dallas: Multiply injured patient presenting le- Heberer); Akademiska Sjukhuset Uppsala, Sweden (Prof. sions to 2 cavities, associated with 2 or more long S. Olerud); University Hospital, Department of Surgery, bone failures; lesions to 1 cavity associated with 2 Basel, Switzerland (Prof. M. Allgiiwer); H6pital de la Piti~, or more long bone failures; or lesions to multiple Paris, France (Prof. R. Roy-Camille); and University of extremities (at minimum, 3 long bone failures). Texas Southwestern Medical School, Dallas, Texas, U.S.A. (Prof. B. Claudi). Their answers have been summarized in a few short paragraphs where tabulation was not possible, Do You Grade Polytrauma, and If So, How? and then mainly in tabular form for convenient comparison among the various centers. There seems to be considerable international agreement on the main points of early aggres- Hannover: Yes, with our own grading system along sive cardiopulmonary management to prevent multiple with ISS and AIS.
    [Show full text]
  • Shock and Hemodynamic Monitoring
    Shock and Hemodynamic Monitoring Matthew Bank, MD, FACS Assistant Professor Hofstra North Shore‐LIJ School of Medicine Director, Surgical Intensive Care Unit North Shore University Hospital I do not have any financial conflicts of interest to disclose for this presentation Shock • Multiple different strategies for classifying shock, but all forms of shock result in impaired oxygen delivery secondary to either one or both: – reduced cardiac output (cardiogenic, septic) OR – loss of effective intravascular volume (hypovolemic, neurogenic, anaphylactic, septic). Septic Shock –Gram Negative • Gram negative septic shock: —Very studied well studied in animal models —Lipopolysaccharide (LPS) in bacterial cell wall binds to LPS binding protein. —LPS‐LBP complex then binds to cell surface CD14 receptors on monocytes and macrophages. —The LPS‐LBP‐CD14 complex then activates cells via Toll‐like receptor‐4 (TLR4). —TLR4 then “activates” cells which produce a cytokine “cascade” of proinflamatory mediators. Septic Shock –Gram Negative • Tumor Necrosis Factor (TNF) – First cytokine produced in response to gram negative sepsis – Principal mediator for acute response to gram negative bacteria – Major source of TNF is from activated macrophages – High levels of TNF predict mortality and can cause apoptosis. Septic Shock –Gram Negative • Interleukin‐1 (IL‐1) – Levels of IL‐1 increase soon after TNF production in gram negative sepsis (second cytokine to be elevated) – IL‐1 produced by macrophages, neutrophils and endothelial cells – IL‐1 increases levels of next proinflammatory cytokines in cascade, IL‐2 and IL‐12. – IL‐1 does NOT cause apoptosis Septic Shock –Gram Negative • Interleukin‐10 – Anti‐inflammatory cytokine – Inhibits production of IL‐12 – Inhibits T‐cell activation Septic Shock –Gram Positive • Gram positive sepsis – Gram positive cell wall components are also known to be involved in septic response – Peptidoglycans – Teichoic Acid – Likely act in a similar manner as LPS, but less potent on a weight bases.
    [Show full text]
  • Pneumonia in the Context of Severe Sepsis: a Significant Diagnostic Problem
    -1 plasma D-dimer level was low (282 mg?L ). Chest radiography affected by antiphospholipid antibodies syndrome and showed multiple ill-defined increased densities in both lower avoided diagnostic surgery. lung fields. High-resolution computed tomography was then In conclusion, we believe that the indications for use of performed and showed ill-defined, wedge-shaped increased endobronchial ultrasound are manifold and are certainly densities with patent airways in the posterior subpleural greater than those so far recognised. This procedure should regions of both lower lobes. The computed tomography therefore be implemented and further developed in interven- differential diagnosis was organising pneumonia, bronchop- tional pneumology. neumonia, Churg–Strauss syndrome, Wegener granulomato- sis, pulmonary haemorrhage, or vasculitis of various causes. Transbronchial lung biopsy was performed in the right lower G.L. Casoni, C. Gurioli, M. Romagnoli and V. Poletti lobe. Microscopic examination showed alveolar haemorrhage Thoracic Dept, G.B. Morgagni Hospital, Forlı´, Italy. without evidence of vasculitis, eosinophilic infiltration or organising pneumonia. Serum circulating antiphospholipid STATEMENT OF INTEREST antibodies were eventually found. Therefore, pulmonary None declared. angiography was performed and an intra-arterial low density was found in the right main pulmonary artery. This finding SUPPLEMENTARY MATERIAL was believed to be compatible with pulmonary thrombo- This article has supplementary material accessible from embolism; however, it didn’t exclude a possible right www.erj.ersjournals.com pulmonary artery sarcoma. In this case, the only procedure that would rule out the presence of a right pulmonary artery sarcoma (without delays in diagnosis) with any reasonable REFERENCES certainty was surgery. 1 Herth F, Becker HD, LoCicero J 3rd, Ernst A., Endobronchial We decided to perform rigid bronchoscopy under general ultrasound in therapeutic bronchoscopy.
    [Show full text]
  • What Is Sepsis?
    What is sepsis? Sepsis is a serious medical condition resulting from an infection. As part of the body’s inflammatory response to fight infection, chemicals are released into the bloodstream. These chemicals can cause blood vessels to leak and clot, meaning organs like the kidneys, lung, and heart will not get enough oxygen. The blood clots can also decrease blood flow to the legs and arms leading to gangrene. There are three stages of sepsis: sepsis, severe sepsis, and ultimately septic shock. In the United States, there are more than one million cases with more than 258,000 deaths per year. More people die from sepsis each year than the combined deaths from prostate cancer, breast cancer, and HIV. More than 50 percent of people who develop the most severe form—septic shock—die. Septic shock is a life-threatening condition that happens when your blood pressure drops to a dangerously low level after an infection. Who is at risk? Anyone can get sepsis, but the elderly, infants, and people with weakened immune systems or chronic illnesses are most at risk. People in healthcare settings after surgery or with invasive central intravenous lines and urinary catheters are also at risk. Any type of infection can lead to sepsis, but sepsis is most often associated with pneumonia, abdominal infections, or kidney infections. What are signs and symptoms of sepsis? The initial symptoms of the first stage of sepsis are: A temperature greater than 101°F or less than 96.8°F A rapid heart rate faster than 90 beats per minute A rapid respiratory rate faster than 20 breaths per minute A change in mental status Additional symptoms may include: • Shivering, paleness, or shortness of breath • Confusion or difficulty waking up • Extreme pain (described as “worst pain ever”) Two or more of the symptoms suggest that someone is becoming septic and needs immediate medical attention.
    [Show full text]
  • Validation of Lactate Clearance at 6 H for Mortality Prediction in Critically Ill Children
    570 Research Article Validation of lactate clearance at 6 h for mortality prediction in critically ill children Rajeev Kumar, Nirmal Kumar Background and Aims: To validate the lactate clearance (LC) at 6 h for mortality Access this article online prediction in Pediatric Intensive Care Unit (PICU)-admitted patients and its comparison Website: www.ijccm.org with a pediatric index of mortality 2 (PIM 2) score. Design: A prospective, observational DOI: 10.4103/0972-5229.192040 study in a tertiary care center. Materials and Methods: Children <13 years of age, Quick Response Code: Abstract admitted to PICU were included in the study. Lactate levels were measured at 0 and 6 h of admission for clearance. LC and delayed or nonclearance group compared for in-hospital mortality and compared with PIM 2 score for mortality prediction. Results: Of the 140 children (mean age 33.42 months) who were admitted to PICU, 23 (16.42%) patients died. For LC cut-off (16.435%) at 6 h, 92 patients qualified for clearance and 48 for delayed or non-LC group. High mortality was observed (39.6%) in delayed or non-LC group as compared to clearance group (4.3%) (P = 0.000). LC cut-off of 16.435% at 6 h (sensitivity 82.6%, specificity 75.2%, positive predictive value 39.6%, and negative predictive value 95.7%) correlates with mortality. Area under receiver operating characteristic (ROC) for LC at 6 h for mortality prediction was 0.823 (P = 0.000). The area under ROC curve for expected mortality prediction by PIM 2 score at admission was 0.906 and at 12.3% cut-off of PIM 2 Score was related with mortality.
    [Show full text]
  • Septic Shock Management Guided by Ultrasound: a Randomized Control Trial (SEPTICUS Trial)
    Septic Shock Management Guided by Ultrasound: A Randomized Control Trial (SEPTICUS Trial) RESEARCH PROTOCOL dr. Saptadi Yuliarto, Sp.A(K), MKes PEDIATRIC EMERGENCY AND INTENSIVE THERAPY SAIFUL ANWAR GENERAL HOSPITAL, MALANG MEDICAL FACULTY OF BRAWIJAYA UNIVERSITY DECEMBER 30, 2020 1 SUMMARY Research Title Septic Shock Management Guided by Ultrasound: A Randomized Control Trial (SEPTICUS Trial) Research Design A multicentre experimental study in pediatric patients with a diagnosis of septic shock. Research Objective To examine the differences in fluid resuscitation outcomes for septic shock patients with the USSM and mACCM protocols • Patient mortality rate • Differences in clinical parameters • Differences in macrocirculation hemodynamic parameters • Differences in microcirculation laboratory parameters Inclusion/Exclusion Criteria Inclusion: Pediatric patients (1 month - 18 years old), diagnosed with septic shock Exclusion: patients with congenital heart defects, already receiving fluid resuscitation or inotropic-vasoactive drugs prior to study recruitment, patients after cardiac surgery Research Setting A multicenter study conducted in all pediatric intensive care units (HCU / PICU), emergency department (IGD), and pediatric wards in participating hospitals in Indonesia. Sample Size Calculating the minimum sample size using the clinical trial formula for the mortality rate, obtained a sample size of 340 samples. Research Period The study was carried out in the period January 2021 to December 2022 Data Collection Process Pediatric patients who met the study inclusion criteria were randomly divided into 2 groups, namely the intervention group (USSM protocol) or the control group (mACCM protocol). Patients who respond well to resuscitation will have their outcome analyzed in the first hour (15-60 minutes). Patients with fluid refractory shock will have their output analyzed at 6 hours.
    [Show full text]
  • Approach to Shock.” These Podcasts Are Designed to Give Medical Students an Overview of Key Topics in Pediatrics
    PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on “Approach to Shock.” These podcasts are designed to give medical students an overview of key topics in pediatrics. The audio versions are accessible on iTunes or at www.pedcases.com/podcasts. Approach to Shock Developed by Dr. Dustin Jacobson and Dr Suzanne Beno for PedsCases.com. December 20, 2016 My name is Dustin Jacobson, a 3rd year pediatrics resident from the University of Toronto. This podcast was supervised by Dr. Suzanne Beno, a staff physician in the division of Pediatric Emergency Medicine at the University of Toronto. Today, we’ll discuss an approach to shock in children. First, we’ll define shock and understand it’s pathophysiology. Next, we’ll examine the subclassifications of shock. Last, we’ll review some basic and more advanced treatment for shock But first, let’s start with a case. Jonny is a 6-year-old male who presents with lethargy that is preceded by 2 days of a diarrheal illness. He has not urinated over the previous 24 hours. On assessment, he is tachycardic and hypotensive. He is febrile at 40 degrees Celsius, and is moaning on assessment, but spontaneously breathing. We’ll revisit this case including evaluation and management near the end of this podcast. The term “shock” is essentially a ‘catch-all’ phrase that refers to a state of inadequate oxygen or nutrient delivery for tissue metabolic demand. This broad definition incorporates many causes that eventually lead to this end-stage state. Basic oxygen delivery is determined by cardiac output and content of oxygen in the blood.
    [Show full text]
  • Septic, Hypovolemic, Obstructive and Cardiogenic Killers
    S.H.O.C.K Septic, Hypovolemic, Obstructive and Cardiogenic Killers Jason Ferguson, BPA, NRP Public Safety Programs Head, CVCC Amherst County DPS, Paramedic Centra One, Flight Paramedic Objectives • Define Shock • Review patho and basic components of life • Identify the types of shock • Identify treatments Shock Defined • “Rude unhinging of the machinery of life”- Samuel Gross, U.S. Trauma Surgeon, 1962 • “A momentary pause in the act of death”- John Warren, U.S. Surgeon, 1895 • Inadequate tissue perfusion Components of Life Blood Flow Right Lungs Heart Left Body Heart Patho Review • Preload • Afterload • Baroreceptors Perfusion Preservation Basic rules of shock management: • Maintain airway • Maintain oxygenation and ventilation • Control bleeding where possible • Maintain circulation • Adequate heart rate and intravascular volume ITLS Cases Case 1 • 11 month old female “not acting right” • Found in crib this am lethargic • Airway patent • Breathing is increased; LS clr • Circulation- weak distal pulses; pale and cool Case 1 • VS: RR 48, HR 140, O2 98%, Cap refill >2 secs • Foul smelling diapers x 1 day • “I must have changed her two dozen times yesterday” • Not eating or drinking much Case 1 • IV established after 4 attempts • Fluid bolus initiated • Transported to ED • Received 2 liters of fluid over next 24 hours Hypovolemic Shock Hemorrhage Diarrhea/Vomiting Hypovolemia Burns Peritonitis Shock Progression Compensated to decompensated • Initial rise in blood pressure due to shunting • Initial narrowing of pulse pressure • Diastolic raised
    [Show full text]
  • Hospital Toolkit for Adult Sepsis Surveillance CS289729-A
    Hospital Toolkit for Adult Sepsis Surveillance CS289729-A MARCH 2018 Centers for Disease Control and Prevention • Division of Healthcare Quality Promotion Table of Contents List of Abbreviations ..............................................................................................................................................................................................................................................................................................................2 Background ...............................................................................................................................................................................................................................................................................................................................................3 Objectives .....................................................................................................................................................................................................................................................................................................................................................3 Surveillance Settings and Appropriate Use .........................................................................................................................................................................................................................4 Definitions ...................................................................................................................................................................................................................................................................................................................................................4
    [Show full text]
  • Pathophysiology of Meningococcal Meningitis and Septicaemia N Pathan, S N Faust, M Levin
    601 CURRENT TOPIC Arch Dis Child: first published as 10.1136/adc.88.7.601 on 1 July 2003. Downloaded from Pathophysiology of meningococcal meningitis and septicaemia N Pathan, S N Faust, M Levin ............................................................................................................................. Arch Dis Child 2003;88:601–607 Neisseria meningitidis is remarkable for the diversity of The human immune system has a number of interactions that the bacterium has with the human host, different mechanisms to limit the growth of meningococci in blood. Both the older innate ranging from asymptomatic nasopharyngeal immune system and acquired immunity through colonisation affecting virtually all members of the antibodies, T and B cells play a role. The population; through focal infections of the meninges, epidemiology of meningococcal disease clearly indicates that the development of specific anti- joints, or eye; to the devastating and often fatal body is the most important immunoprotective syndrome of meningococcal septic shock and purpura mechanism.78 The peak incidence of the disease fulminans. occurs in the first year of life following the loss of maternal antibody; the disease becomes progres- .......................................................................... sively less common throughout childhood and is extremely rare in adults, a pattern suggestive of a n the past few decades, considerable progress major role for acquired immunity through anti- has been made in understanding the complex bodies. The studies
    [Show full text]
  • Central Venous Catheter Insertion in Septic Patients
    Central Venous Catheter Insertion in Septic Patients Admitted From the Emergency Department: It Is All in the Timing Rohit Mittal, Emory University Craig Coopersmith, Emory University Journal Title: Critical Care Medicine Volume: Volume 42, Number 3 Publisher: Lippincott, Williams & Wilkins | 2014-03-01, Pages 735-736 Type of Work: Article | Post-print: After Peer Review Publisher DOI: 10.1097/01.ccm.0000435693.15963.60 Permanent URL: https://pid.emory.edu/ark:/25593/txth7 Final published version: http://dx.doi.org/10.1097/01.ccm.0000435693.15963.60 Copyright information: (C) 2014 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins Accessed September 28, 2021 2:47 PM EDT NIH Public Access Author Manuscript Crit Care Med. Author manuscript; available in PMC 2015 March 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Crit Care Med. 2014 March ; 42(3): 735–736. doi:10.1097/01.ccm.0000435693.15963.60. Central venous catheter insertion in septic patients admitted from the emergency department: it’s all in the timing Rohit Mittal, MD and Craig M. Coopersmith, MD, FCCM Emory Center for Critical Care and Department of Surgery, Emory University School of Medicine, Atlanta, GA Management of sepsis is time sensitive. The faster therapy is initiated, the higher the likelihood for a positive outcome. While the optimal treatment for severe sepsis and septic shock is multifactorial, a cornerstone of management includes placement of a central venous catheter (CVC) in order to administer vasoactive agents, and measure central venous pressure and central venous oxygenation when appropriate.
    [Show full text]